Preview Mode Links will not work in preview mode

This Week in Cardiology

Aug 20, 2021

COVID-19, Simpson’s Paradox, LAA appendage closure, multimorbidity, and an ESC preview are the topics John Mandrola, MD discusses in today’s podcast.

1 - COVID-19

- Lacking Beds, Hospitals Ship COVID-19 Patients to Other States

- Efficacy and Safety of Same-Day Discharge for Atrial Fibrillation Ablation

2 - Simpson’s Paradox

- Israeli data: How can efficacy vs. severe disease be strong when 60% of hospitalized are vaccinated?

- Simpson’s Paradox and Interpreting Data

- How SIMPSON'S PARADOX explains weird COVID19 statistics

3 - Left Atrial Appendage Closure

- FDA Approves Abbott's Amplatzer Amulet for Atrial Fibrillation

- Chronic Kidney Disease Tied to Worse LAAO Outcomes

- The Association of Chronic Kidney Disease With Outcomes Following Percutaneous Left Atrial Appendage Closure

- Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis

4 - ESC Preview

- SGLT2 inhibitors in HFpEF

- EMPEROR-Preserved: Positive Top-Line Results for Empagliflozin in HFpEF

- AF Screening

- Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial

5 - Coming soon

The anticoagulation in COVID-19 trial is one of the hardest I have seen in years. Stay tuned.

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact